source
- Two biotech firms raise $556 million in combined IPOsSeaport Therapeutics and Hemab Therapeutics launched initial public offerings on Thursday, together bringing in $556.4 million to fund further development of their drug pipelines. Hemab Therapeuti…
- Moderna reports Q1 revenue surge driven by international COVID vaccine sales despite larger net lossModerna posted first‑quarter revenue of $389 million, more than triple the same period a year earlier, primarily from overseas COVID‑19 vaccine sales. The company recorded a net loss of $1.3 billi…